MedPath

PSA TOOL for Prostate Cancer Screening Discussions

Not Applicable
Completed
Conditions
Prostate Cancer
Registration Number
NCT03135444
Lead Sponsor
Case Comprehensive Cancer Center
Brief Summary

The study team created a tool to help identify patients who may benefit from shared decision making in the primary care setting. This tool is a guide to aid in decision making for prostate cancer screening. The team proposes the topics to be discussed in the screening conversation include the risk for developing prostate cancer based upon age, race/ethnicity, family history of prostate cancer, history of previous digital rectal exam, and history of previous prostate specific antigen (PSA) as well as self-reported health status and preferences for treatment. The team now proposes 1) testing this tool first for ease of use in primary care clinics 2) revising this tool based upon feedback from patients and providers, then 3) testing this tool for effectiveness in improving patient knowledge that they have an option to be screened for prostate cancer and of specific factors to be considered in the screening decision.

Detailed Description

Objectives:

1. To pilot test a decision making tool, the PSA TOOL, for prostate cancer screening for usefulness and ease of use in primary care practices.

2. To revise the PSA TOOL based upon provider and patient feedback.

3. To assess patient knowledge about the option to be screened for prostate cancer and factors to consider in the prostate cancer screening decision before and after use of the tool.

Study Design:

This protocol is for field testing of a brief tool to improve prostate cancer screening discussions that occur at previously scheduled primary care outpatient visits.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
95
Inclusion Criteria

Provider:

  • Provider at selected primary care practices in the Cleveland Clinic Health System
  • Willing to utilize a guide to aid in decision making for prostate cancer screening

Patient:

  • Patient of participating Cleveland Clinic primary care provider who is scheduled for a routine appointment with the provider
Exclusion Criteria
  • Not a patient or provider of the Cleveland Clinic Health System

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Score from Perceived Usefulness scaleUp to 4 weeks after getting PSA TOOL

scale will be summarized as means and standard deviations

Score from Perceived Ease of Use scaleUp to 4 weeks after getting PSA TOOL

scale will be summarized as means and standard deviations

Change in Score from Pre-Test to Post-TestUp to 30 minutes after Pre-Test

The paired t-test will be used to compare the pre- and post- patient survey scores

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cleveland Clinic, Case Comprehensive Cancer Center

🇺🇸

Cleveland, Ohio, United States

Cleveland Clinic, Case Comprehensive Cancer Center
🇺🇸Cleveland, Ohio, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.